🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Gestational Diabetes

Recruitingn/aAges 18 Years - anyFemaleUniversity Hospital Tuebingen
NCT04270578 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Due to a changed lifestyle with less physical activity, unfavorable diets rich in fat and calories and obesity, the prevalence of diabetes mellitus is increasing worldwide. The diabetes epidemic is associated with significant personal and socio-economic consequences. Despite attempts to prevent the complications of diabetes, this disease is still the leading cause of blindness, chronic renal insufficiency and non-traumatic amputation. It is important to detect early on an increase in blood sugar and treat it accordingly to reduce costs and to minimize the personal suffering of those affected. As the number of patients with type 2 diabetes mellitus continues to rise, the number of young women with gestational diabetes mellitus (GDM) also increases. This is a disorder og glucose metabolism, which occurs for the first time in pregnancy. The causes for this are manifold. Among other causes,

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: \- Signed and dated informed consent Enrollment is possible during AND after gestation: * Baseline visit (pregnancy): gestational week 24+0 till 31+6 * Postpartum visits: documented occurence of GDM in previous pregnancy Exclusion Criteria: * Age \< 18years * Diabetes Mellitus Type 1 or Type 2 * GFR \< 60 ml/min/1,73 m2 * CRP \> 1 mg/dl * Increased levels of transaminases 2 fold above ULN * Preexisting cardiac conditions * Weight loss \> 10% within 6 months prior to inclusion * Psychiatric disorders * Chronic alcohol or substance abuse * Blood sugar increasing or decreasing drug therapy, e.g. steroids, antidiabetics, insulin * only postpartum visits: pregnancy or lactation
💊

What it tests

  • Not listed
📍

Where

1 site
University Hospital Tuebingen
Tübingen, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy